Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

62°
- Benton, AR (72018)
  Today
  
  Sunny. High 77F. Winds S at 5 to 10 mph..
  
  Tonight
  
  Some clouds. Low 56F. Winds light and variable.
  
  Updated: May 8, 2026 @ 9:30 am
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Evolus, Inc. - Common Stock (NQ:EOLS)

6.520 +0.130 (+2.03%)

Streaming Delayed Price Updated: 10:33 AM EDT, May 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evolus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Evolus Reaches 1 Million Redemptions in its Evolus Rewards™ Patient Loyalty Program

June 08, 2023

From Evolus

Via Business Wire

Expert Ratings for Evolus ↗

May 26, 2023

Via Benzinga

This Analyst Likes Evolus As 'Top Play In Aesthetics' ↗

May 10, 2023

Evolus Inc (NASDAQ: EOLS) will be the exclusive U.S.

Via Benzinga

Expert Ratings for Evolus ↗

May 10, 2023

Via Benzinga

Evolus: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Evolus Reports First Quarter 2023 Results and Provides Business Update

May 09, 2023

From Evolus

Via Business Wire

Evolus Earnings Preview ↗

May 08, 2023

Via Benzinga

Analyst Expectations for Evolus's Future ↗

March 09, 2023

Via Benzinga

Preview: Evolus's Earnings ↗

March 07, 2023

Via Benzinga

Evolus Says 'Extra Strength' Jeuveau Shows A Durable Effect In Frown Lines ↗

January 30, 2023

Via Benzinga

Why Evolus Shares Jumped This Week ↗

January 20, 2023

The company said it expects to turn a profit in the fourth quarter.

Via The Motley Fool

Evolus Announces Expansion into U.S. Dermal Filler Market with Evolysse™, a First-Generation Cold Technology HA by Symatese

May 09, 2023

From Evolus, Inc.

Via Business Wire

Evolus to Report First Quarter 2023 Results and Provide Business Update

May 05, 2023

From Evolus, Inc.

Via Business Wire

Evolus Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

March 08, 2023

From Evolus

Via Business Wire

Earnings Scheduled For March 8, 2023 ↗

March 08, 2023

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.

Via Benzinga

Evolus to Participate in the Barclays Global Healthcare Conference

February 28, 2023

From Evolus

Via Business Wire

Evolus Initiates Nuceiva® Launch in Germany and Austria

February 27, 2023

From Evolus, Inc.

Via Business Wire

Evolus to Report Fourth Quarter and Year End 2022 Results and Provide Business Update

February 22, 2023

From Evolus

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 17, 2023

Via Benzinga

Evolus Not Affected by Recent Korean Court Ruling

February 10, 2023

From Evolus

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 07, 2023

Via Benzinga

Evolus to Participate in the SVB Securities Global Biopharma Conference

January 31, 2023

From Evolus

Via Business Wire

"Extra-Strength" Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance

January 28, 2023

From Evolus

Via Business Wire

Evolus Receives Regulatory Approval for Nuceiva® in Australia

January 23, 2023

From Evolus

Via Business Wire

Evolus to Present Phase 2 Interim Data from Jeuveau® “Extra-Strength” Dose for Extended Duration Study at 2023 IMCAS World Congress

January 23, 2023

From Evolus

Via Business Wire

Here's Why This Analyst Seems Highly Convinced With Evolus' Outlook ↗

January 19, 2023

Evolus Inc (NASDAQ: EOLS) issued fourth-quarter 2022 and full-year 2022 revenues of $43.6 million, up 26% Y/Y and approximately $148.6 million, up 49%, respectively.

Via Benzinga

Why Evolus Shares Are Trading Higher Today ↗

January 18, 2023

Evolus, Inc. (NASDAQ: EOLS) shares are trading higher after the company issued fourth-quarter and full-year 2022 and announced full-year 2023 revenue guidance.

Via Benzinga

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 18, 2023

Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Evolus, Inc. - Common Stock (NQ:EOLS)

All News about Evolus, Inc. - Common Stock

Sections

Services

Follow Us